Review



reagent 3  (Elabscience Biotechnology)


Bioz Verified Symbol Elabscience Biotechnology is a verified supplier
Bioz Manufacturer Symbol Elabscience Biotechnology manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Elabscience Biotechnology reagent 3
    Reagent 3, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 124 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/reagent 3/product/Elabscience Biotechnology
    Average 96 stars, based on 124 article reviews
    reagent 3 - by Bioz Stars, 2026-05
    96/100 stars

    Images



    Similar Products

    97
    Complete Genomics Inc cpas barcode primer 3 kit
    Cpas Barcode Primer 3 Kit, supplied by Complete Genomics Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cpas barcode primer 3 kit/product/Complete Genomics Inc
    Average 97 stars, based on 1 article reviews
    cpas barcode primer 3 kit - by Bioz Stars, 2026-05
    97/100 stars
      Buy from Supplier

    97
    Sartorius AG caspase 3 7 green reagent
    Caspase 3 7 Green Reagent, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/caspase 3 7 green reagent/product/Sartorius AG
    Average 97 stars, based on 1 article reviews
    caspase 3 7 green reagent - by Bioz Stars, 2026-05
    97/100 stars
      Buy from Supplier

    86
    10X Genomics chromium single cell 3 reagent kit v3 1
    Chromium Single Cell 3 Reagent Kit V3 1, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/chromium single cell 3 reagent kit v3 1/product/10X Genomics
    Average 86 stars, based on 1 article reviews
    chromium single cell 3 reagent kit v3 1 - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    96
    Elabscience Biotechnology reagent 3
    Reagent 3, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/reagent 3/product/Elabscience Biotechnology
    Average 96 stars, based on 1 article reviews
    reagent 3 - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    90
    10X Genomics single cell 3 'reagent kits v2 kit
    Single Cell 3 'Reagent Kits V2 Kit, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/single cell 3 'reagent kits v2 kit/product/10X Genomics
    Average 90 stars, based on 1 article reviews
    single cell 3 'reagent kits v2 kit - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    96
    TaKaRa primescript rt reagent kit
    Primescript Rt Reagent Kit, supplied by TaKaRa, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primescript rt reagent kit/product/TaKaRa
    Average 96 stars, based on 1 article reviews
    primescript rt reagent kit - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    96
    Vector Laboratories 3 3 diaminobenzidine
    3 3 Diaminobenzidine, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/3 3 diaminobenzidine/product/Vector Laboratories
    Average 96 stars, based on 1 article reviews
    3 3 diaminobenzidine - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    97
    Sartorius AG incucyte caspase 3 7 green dye apoptosis reagent
    a , Comparison of serum BA profile as total and average percent composition in C57BL/6J mice (8 weeks, male, n=5), C57BLKS mice (8 weeks, male, n = 3) and db/db mice (8 weeks, male, n = 5), non-diabetic NOD mice (19 weeks, female, n = 9), diabetic NOD mice (19 weeks, female, n = 7). b, Comparison of serum individual BA amount in C57BL/6J (non-diabetic control, n = 5), C57BLKS (non-diabetic control, n = 3) and db/db (diabetic, n = 5). c, Comparison of serum individual BA amount in non-diabetic (n = 9) and diabetic (n = 7) female NOD mice at 19 weeks of age. d, <t>Caspase</t> <t>3/7</t> green count in EndoC-βH1 cells for 240 hours treatment with different BAs in the presence of IL-1β (10 ng/ml) and IFNγ (10 ng/ml). n = 4/each. e , Caspase 3/7 green count in EndoC-βH1 cells at 14 days treatment with different BAs in the presence of IL-1β (10 ng/ml) and IFNγ (10 ng/ml). n = 4/each. f , Caspase 3/7 green count in EndoC-βH1 cells at 240 hours treatment after addition of Fex (10 μμ) in the presence of BAs (10 μM each), IL-1β (10 ng/ml) and IFNγ (10 ng/ml) (n = 3/each). Statistical analyses were performed using one-way ANOVA with Tukey’s multiple-comparison test per bile acid (BA) condition for (b, e), unpaired two-tailed Student’s t-test per BA condition for (c, f), and two-way ANOVA for (d). Error bars represent mean ± SEM.
    Incucyte Caspase 3 7 Green Dye Apoptosis Reagent, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/incucyte caspase 3 7 green dye apoptosis reagent/product/Sartorius AG
    Average 97 stars, based on 1 article reviews
    incucyte caspase 3 7 green dye apoptosis reagent - by Bioz Stars, 2026-05
    97/100 stars
      Buy from Supplier

    Image Search Results


    a , Comparison of serum BA profile as total and average percent composition in C57BL/6J mice (8 weeks, male, n=5), C57BLKS mice (8 weeks, male, n = 3) and db/db mice (8 weeks, male, n = 5), non-diabetic NOD mice (19 weeks, female, n = 9), diabetic NOD mice (19 weeks, female, n = 7). b, Comparison of serum individual BA amount in C57BL/6J (non-diabetic control, n = 5), C57BLKS (non-diabetic control, n = 3) and db/db (diabetic, n = 5). c, Comparison of serum individual BA amount in non-diabetic (n = 9) and diabetic (n = 7) female NOD mice at 19 weeks of age. d, Caspase 3/7 green count in EndoC-βH1 cells for 240 hours treatment with different BAs in the presence of IL-1β (10 ng/ml) and IFNγ (10 ng/ml). n = 4/each. e , Caspase 3/7 green count in EndoC-βH1 cells at 14 days treatment with different BAs in the presence of IL-1β (10 ng/ml) and IFNγ (10 ng/ml). n = 4/each. f , Caspase 3/7 green count in EndoC-βH1 cells at 240 hours treatment after addition of Fex (10 μμ) in the presence of BAs (10 μM each), IL-1β (10 ng/ml) and IFNγ (10 ng/ml) (n = 3/each). Statistical analyses were performed using one-way ANOVA with Tukey’s multiple-comparison test per bile acid (BA) condition for (b, e), unpaired two-tailed Student’s t-test per BA condition for (c, f), and two-way ANOVA for (d). Error bars represent mean ± SEM.

    Journal: bioRxiv

    Article Title: FXR and BET signaling orchestrate to protect β cells

    doi: 10.64898/2026.04.10.716420

    Figure Lengend Snippet: a , Comparison of serum BA profile as total and average percent composition in C57BL/6J mice (8 weeks, male, n=5), C57BLKS mice (8 weeks, male, n = 3) and db/db mice (8 weeks, male, n = 5), non-diabetic NOD mice (19 weeks, female, n = 9), diabetic NOD mice (19 weeks, female, n = 7). b, Comparison of serum individual BA amount in C57BL/6J (non-diabetic control, n = 5), C57BLKS (non-diabetic control, n = 3) and db/db (diabetic, n = 5). c, Comparison of serum individual BA amount in non-diabetic (n = 9) and diabetic (n = 7) female NOD mice at 19 weeks of age. d, Caspase 3/7 green count in EndoC-βH1 cells for 240 hours treatment with different BAs in the presence of IL-1β (10 ng/ml) and IFNγ (10 ng/ml). n = 4/each. e , Caspase 3/7 green count in EndoC-βH1 cells at 14 days treatment with different BAs in the presence of IL-1β (10 ng/ml) and IFNγ (10 ng/ml). n = 4/each. f , Caspase 3/7 green count in EndoC-βH1 cells at 240 hours treatment after addition of Fex (10 μμ) in the presence of BAs (10 μM each), IL-1β (10 ng/ml) and IFNγ (10 ng/ml) (n = 3/each). Statistical analyses were performed using one-way ANOVA with Tukey’s multiple-comparison test per bile acid (BA) condition for (b, e), unpaired two-tailed Student’s t-test per BA condition for (c, f), and two-way ANOVA for (d). Error bars represent mean ± SEM.

    Article Snippet: Caspase 3/7 cell apoptosis assays were performed using IncuCyte Caspase 3/7 green dye apoptosis reagent (Sartorius, 4440) and monitored using the IncuCyte SX5 live cell analysis instrument with according to the manufacturer’s protocol.

    Techniques: Comparison, Control, Two Tailed Test

    a , Heatmap of FXR gene expression and β cell marker genes in human iPSCs during their stepwise differentiation into HILOs compared to human islets, HUVEC cells, and EndoC-βH1. b , NR1H4 gene expression in human islets and hPSC-derived pancreatic cells. Data was obtained from single cell Portal Broad institute (Functional, metabolic and transcriptional maturation of human pancreatic islets derived from stem cells). c , Representative image of FXR Western blot for endogenous and DOX-induced FXR overexpression system in EndoC-βH1 human β cell line. d , NR1H4 expression in human tissues. Data was obtained from GTEx Portal. e , FXR reporter assay after 24 hours of treatment with DMSO, Fex (10 μM) or GW4064 (10 μM) in HEK293LTV and EndoC-βH1 cells. n = 3/each. f , TGR5-luciferase in EndoC-βH1 and HEK293LTV cell lines containing the TGR5 luciferase reporter after 24 hours treatment with the FXR-specific agonist Fex. n = 3/each. g , FXRE (FXR responsive element)-luciferase reporter signal of different BAs (10 μM each for indicated time) and Fex on EndoC-βH1 cells after 24 hours and 72 hours treatment. n = 4/each. h , Real-time imaging of caspase 3/7 green intensity signal in EndoC-βH1 cell line for 60 hours incubation with BAs (10 μM each for indicated time) without inflammatory cytokine IL-1β. n = 4/each. Statistical analyses were performed using unpaired Student’s two-tailed t-tests for (f), one-way ANOVA with Tukey’s multiple-comparison test for (e, g), and two-way ANOVA for (h). Error bars represent mean ± SEM.

    Journal: bioRxiv

    Article Title: FXR and BET signaling orchestrate to protect β cells

    doi: 10.64898/2026.04.10.716420

    Figure Lengend Snippet: a , Heatmap of FXR gene expression and β cell marker genes in human iPSCs during their stepwise differentiation into HILOs compared to human islets, HUVEC cells, and EndoC-βH1. b , NR1H4 gene expression in human islets and hPSC-derived pancreatic cells. Data was obtained from single cell Portal Broad institute (Functional, metabolic and transcriptional maturation of human pancreatic islets derived from stem cells). c , Representative image of FXR Western blot for endogenous and DOX-induced FXR overexpression system in EndoC-βH1 human β cell line. d , NR1H4 expression in human tissues. Data was obtained from GTEx Portal. e , FXR reporter assay after 24 hours of treatment with DMSO, Fex (10 μM) or GW4064 (10 μM) in HEK293LTV and EndoC-βH1 cells. n = 3/each. f , TGR5-luciferase in EndoC-βH1 and HEK293LTV cell lines containing the TGR5 luciferase reporter after 24 hours treatment with the FXR-specific agonist Fex. n = 3/each. g , FXRE (FXR responsive element)-luciferase reporter signal of different BAs (10 μM each for indicated time) and Fex on EndoC-βH1 cells after 24 hours and 72 hours treatment. n = 4/each. h , Real-time imaging of caspase 3/7 green intensity signal in EndoC-βH1 cell line for 60 hours incubation with BAs (10 μM each for indicated time) without inflammatory cytokine IL-1β. n = 4/each. Statistical analyses were performed using unpaired Student’s two-tailed t-tests for (f), one-way ANOVA with Tukey’s multiple-comparison test for (e, g), and two-way ANOVA for (h). Error bars represent mean ± SEM.

    Article Snippet: Caspase 3/7 cell apoptosis assays were performed using IncuCyte Caspase 3/7 green dye apoptosis reagent (Sartorius, 4440) and monitored using the IncuCyte SX5 live cell analysis instrument with according to the manufacturer’s protocol.

    Techniques: Gene Expression, Marker, Derivative Assay, Single Cell, Functional Assay, Western Blot, Over Expression, Expressing, Reporter Assay, Luciferase, Imaging, Incubation, Two Tailed Test, Comparison

    a , Upregulated genes and corresponding gene ontology pathway of islets from Veh-treated vs Fex+JQ1-treated db/db mice. n = 3/each. b , Downregulated genes and corresponding gene ontology pathway of islets from Veh-treated vs Fex + JQ1-treated db/db mice. n = 3/each . c , Heatmap of z-score of selected upregulated genes by Fex + JQ1 treatment related to glucose response and insulin secretion pathway. n = 3/each. d , Heatmap of z-score of selected downregulated genes by Fex + JQ1 treatment related to inflammation and apoptosis pathway. n = 3/each. e , Promoter motif analysis of the 552 upregulated genes or 1,186 downregulated genes by Fex + JQ1 treatment. f , Chemical structures and illustration of selective BD domain inhibitors, JQ1, BD1i and BD2i. g , Fasting blood glucose (mg/dL) of db/db mice during the 8-week i.p. treatment with BD2i single treatment and Fex + iBET-BD2 combination treatment. Gray bar shows Veh, Fex, JQ1, or Fex+JQ1 combination . Experiments were performed simultaneously with the experiments in cohort 2. n = 5/each. h , Fed ad lib blood glucose (mg/dL) of db/db mice on the 12-week of i.p. treatment with BD2i vs Fex + BD2i. n = 5/each. Statistical analyses were performed using two-way ANOVA for (g) and one-way ANOVA with Tukey’s multiple-comparison test for (h). Error bars represent mean ± SEM.

    Journal: bioRxiv

    Article Title: FXR and BET signaling orchestrate to protect β cells

    doi: 10.64898/2026.04.10.716420

    Figure Lengend Snippet: a , Upregulated genes and corresponding gene ontology pathway of islets from Veh-treated vs Fex+JQ1-treated db/db mice. n = 3/each. b , Downregulated genes and corresponding gene ontology pathway of islets from Veh-treated vs Fex + JQ1-treated db/db mice. n = 3/each . c , Heatmap of z-score of selected upregulated genes by Fex + JQ1 treatment related to glucose response and insulin secretion pathway. n = 3/each. d , Heatmap of z-score of selected downregulated genes by Fex + JQ1 treatment related to inflammation and apoptosis pathway. n = 3/each. e , Promoter motif analysis of the 552 upregulated genes or 1,186 downregulated genes by Fex + JQ1 treatment. f , Chemical structures and illustration of selective BD domain inhibitors, JQ1, BD1i and BD2i. g , Fasting blood glucose (mg/dL) of db/db mice during the 8-week i.p. treatment with BD2i single treatment and Fex + iBET-BD2 combination treatment. Gray bar shows Veh, Fex, JQ1, or Fex+JQ1 combination . Experiments were performed simultaneously with the experiments in cohort 2. n = 5/each. h , Fed ad lib blood glucose (mg/dL) of db/db mice on the 12-week of i.p. treatment with BD2i vs Fex + BD2i. n = 5/each. Statistical analyses were performed using two-way ANOVA for (g) and one-way ANOVA with Tukey’s multiple-comparison test for (h). Error bars represent mean ± SEM.

    Article Snippet: Caspase 3/7 cell apoptosis assays were performed using IncuCyte Caspase 3/7 green dye apoptosis reagent (Sartorius, 4440) and monitored using the IncuCyte SX5 live cell analysis instrument with according to the manufacturer’s protocol.

    Techniques: Comparison

    a , Schematic of the differentiation strategy into HILOs. IHC of insulin Alexa-488 and DAPI of day 30 HILOs are shown. Illustration of the protocol for iPSC-derived human islet-like organoid (HILO) in vitro T1D and T2D models. T2D includes HILO with DOX-induced overexpression of human IAPP and TXNIP. The T1D HILO model is the co-incubation of HILO with peripheral blood mononuclear cells carrying the matched with HLA-A*01:01 HLA-B*08:01, HLA-C*07:01 HLA-DRB1*03:01 as the HILO. Scheme of partially HLA-matching was shown. b , Apoptosis rate in dispersed HILOs was measured by real-time imaging using Incucyte SX5. Dispersed HILOs were treated with DMSO, Fex (10 µM), JQ1 (500 nM), BD2i (1 µM), Fex (10 µM) + JQ1 (500 nM), or Fex (10 µM) + BD2i (1 µM), in the presence of IL-1β (10 ng/ml) and IFNγ (10 ng/ml). n = 3/each. Apoptosis was visualized by Caspase 3/7 green fluorescence. Bar graph shows green (apoptosis) cell count at 120 hours. c , Caspase 3/7 green (Green = Caspase 3/7 activity/Orange = human TXNIP/IAPPOE cells count) of T2D HILO model (DOX-inducible human TXNIP and human IAPP inducing) during 120 hours treatment of DMSO, Fex (10 µM), JQ1 (500 nM), BD2i (1 µM), Fex (10 µM) + JQ1 (500 nM), or Fex (10 µM) + BD2i (1 µM). n = 3/each. d , Apoptosis rate in dispersed HILOs was measured by real-time imaging using Incucyte SX5. Dispersed HILOs were co-cultured with human T1DPBMC and treated with Fex (10 µM), JQ1 (500 nM), BD1i (1 µM), or BD2i (1 µM) with or without IFNγ (10 ng/ml) for 120 hours. n = 3/each. e , Apoptosis rate in dispersed HILOs was measured by real-time imaging using Incucyte SX5. Dispersed HILOs were co-cultured with human T1DPBMC and treated with Fex (10 µM), JQ1 (500 nM), BD1i (1 µM), or BD2i (1 µM) with or without IFNγ (10 ng/ml) for 120 hours. Thap (Thapsigargin, ER stress inducer, 5 µM) were pretreated to enhance the expression of misfolded insulin prior to imaging. n = 3/each. Statistical analyses were performed using two-way ANOVA for the left panels of (b–e) and one-way ANOVA with Tukey’s multiple-comparison test for the right panels of (b–e). Error bars represent mean ± SEM.

    Journal: bioRxiv

    Article Title: FXR and BET signaling orchestrate to protect β cells

    doi: 10.64898/2026.04.10.716420

    Figure Lengend Snippet: a , Schematic of the differentiation strategy into HILOs. IHC of insulin Alexa-488 and DAPI of day 30 HILOs are shown. Illustration of the protocol for iPSC-derived human islet-like organoid (HILO) in vitro T1D and T2D models. T2D includes HILO with DOX-induced overexpression of human IAPP and TXNIP. The T1D HILO model is the co-incubation of HILO with peripheral blood mononuclear cells carrying the matched with HLA-A*01:01 HLA-B*08:01, HLA-C*07:01 HLA-DRB1*03:01 as the HILO. Scheme of partially HLA-matching was shown. b , Apoptosis rate in dispersed HILOs was measured by real-time imaging using Incucyte SX5. Dispersed HILOs were treated with DMSO, Fex (10 µM), JQ1 (500 nM), BD2i (1 µM), Fex (10 µM) + JQ1 (500 nM), or Fex (10 µM) + BD2i (1 µM), in the presence of IL-1β (10 ng/ml) and IFNγ (10 ng/ml). n = 3/each. Apoptosis was visualized by Caspase 3/7 green fluorescence. Bar graph shows green (apoptosis) cell count at 120 hours. c , Caspase 3/7 green (Green = Caspase 3/7 activity/Orange = human TXNIP/IAPPOE cells count) of T2D HILO model (DOX-inducible human TXNIP and human IAPP inducing) during 120 hours treatment of DMSO, Fex (10 µM), JQ1 (500 nM), BD2i (1 µM), Fex (10 µM) + JQ1 (500 nM), or Fex (10 µM) + BD2i (1 µM). n = 3/each. d , Apoptosis rate in dispersed HILOs was measured by real-time imaging using Incucyte SX5. Dispersed HILOs were co-cultured with human T1DPBMC and treated with Fex (10 µM), JQ1 (500 nM), BD1i (1 µM), or BD2i (1 µM) with or without IFNγ (10 ng/ml) for 120 hours. n = 3/each. e , Apoptosis rate in dispersed HILOs was measured by real-time imaging using Incucyte SX5. Dispersed HILOs were co-cultured with human T1DPBMC and treated with Fex (10 µM), JQ1 (500 nM), BD1i (1 µM), or BD2i (1 µM) with or without IFNγ (10 ng/ml) for 120 hours. Thap (Thapsigargin, ER stress inducer, 5 µM) were pretreated to enhance the expression of misfolded insulin prior to imaging. n = 3/each. Statistical analyses were performed using two-way ANOVA for the left panels of (b–e) and one-way ANOVA with Tukey’s multiple-comparison test for the right panels of (b–e). Error bars represent mean ± SEM.

    Article Snippet: Caspase 3/7 cell apoptosis assays were performed using IncuCyte Caspase 3/7 green dye apoptosis reagent (Sartorius, 4440) and monitored using the IncuCyte SX5 live cell analysis instrument with according to the manufacturer’s protocol.

    Techniques: Derivative Assay, In Vitro, Over Expression, Incubation, Imaging, Fluorescence, Cell Characterization, Activity Assay, Cell Culture, Expressing, Comparison

    a , Representative image of 3D culture system to generate HILOs. Scale bar = 50 µm. b , DOX-inducible human TXNIP and human IAPP overexpression in dispersed HILOs. IB for TXNIP, Amylin (IAPP), PERK, cleaved caspase 3 and β-actin. c , Apoptosis rate in dispersed HILOs was measured by real-time imaging using Incucyte SX5. Dispersed HILOs were treated with DOX (1 µg/µl), IL-1β (10 ng/ml), and IFNγ (10 ng/ml) for 120 hours. n = 3/each. Apoptosis rate was determined by green-integrated intensity, green count and orange-green count (DOX-inducible TXNIP/IAPP coexpress mCherry and it’s overlapping to Caspase 3/7 green fluorescence) respectively. n = 3/each. d , Apoptosis rate in dispersed HILOs was measured by real-time imaging using Incucyte SX5. Dispersed HILOs were treated with Fex (10 µM), JQ1 (500 nM), or iBET-BD2 (1 µM) under the stimulation of DOX (1 µg/µl), IL-1β (10 ng/ml), and IFNγ (10 ng/ml) for 120 hours. n = 3/each. Apoptosis rate was determined by orange-green count (DOX-inducible TXNIP/IAPP coexpress mCherry, which is colocalized with Caspase 3/7 green fluorescence) respectively. n = 3/each. Statistical analyses were performed using one-way ANOVA with Tukey’s multiple-comparison test for (c, d). Error bars represent mean ± SEM.

    Journal: bioRxiv

    Article Title: FXR and BET signaling orchestrate to protect β cells

    doi: 10.64898/2026.04.10.716420

    Figure Lengend Snippet: a , Representative image of 3D culture system to generate HILOs. Scale bar = 50 µm. b , DOX-inducible human TXNIP and human IAPP overexpression in dispersed HILOs. IB for TXNIP, Amylin (IAPP), PERK, cleaved caspase 3 and β-actin. c , Apoptosis rate in dispersed HILOs was measured by real-time imaging using Incucyte SX5. Dispersed HILOs were treated with DOX (1 µg/µl), IL-1β (10 ng/ml), and IFNγ (10 ng/ml) for 120 hours. n = 3/each. Apoptosis rate was determined by green-integrated intensity, green count and orange-green count (DOX-inducible TXNIP/IAPP coexpress mCherry and it’s overlapping to Caspase 3/7 green fluorescence) respectively. n = 3/each. d , Apoptosis rate in dispersed HILOs was measured by real-time imaging using Incucyte SX5. Dispersed HILOs were treated with Fex (10 µM), JQ1 (500 nM), or iBET-BD2 (1 µM) under the stimulation of DOX (1 µg/µl), IL-1β (10 ng/ml), and IFNγ (10 ng/ml) for 120 hours. n = 3/each. Apoptosis rate was determined by orange-green count (DOX-inducible TXNIP/IAPP coexpress mCherry, which is colocalized with Caspase 3/7 green fluorescence) respectively. n = 3/each. Statistical analyses were performed using one-way ANOVA with Tukey’s multiple-comparison test for (c, d). Error bars represent mean ± SEM.

    Article Snippet: Caspase 3/7 cell apoptosis assays were performed using IncuCyte Caspase 3/7 green dye apoptosis reagent (Sartorius, 4440) and monitored using the IncuCyte SX5 live cell analysis instrument with according to the manufacturer’s protocol.

    Techniques: Over Expression, Imaging, Fluorescence, Comparison